Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.50 (-0.77%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.37m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Director/PDMR Shareholding

30 Jun 2008 09:43

RNS Number : 8282X
Macfarlane Group PLC
30 June 2008
 
Macfarlane Group PLC
Director/PDMR shareholding
This notification is made in accordance with DTR. 3. 1.4(1)(a).
On 30 June 2008, the following awards over ordinary shares in the Company were made under the Macfarlane Group PLC Long Term Incentive Plan (the "Plan") to Directors of the Company and other Persons Discharging Managerial Responsibility ("PDMRs"):

Name of Director/PDMR Number of shares under the Award

 

Peter Atkinson 581,706
John Love 270,275
Graham Casey 258,763
Andrew Cotton 175,959
Ivor Gray 190,451

 

No consideration was paid for the grant of the award which is structured as a conditional award.

The vesting of an award is subject to continued employment of the participant and the satisfaction of performance conditions set by the Remuneration Committee of the Company. The award will normally vest on the later of the third anniversary of grant and the determination of the performance conditions.

The Company was informed of the above transactions on 30 June 2008.
Name of contact and telephone number for queries: Andrew Cotton 0141 333 9666
For and on behalf of Macfarlane Group PLC

Andrew Cotton Date: 30 June 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDLIDXGGIG
Date   Source Headline
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20217:00 amRNSNotice of AGM
6th Apr 20217:00 amRNSAnnual Report 2020
1st Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSDirector/PDMR Shareholding
4th Mar 20214:41 pmRNSSecond Price Monitoring Extn
4th Mar 20214:35 pmRNSPrice Monitoring Extension
4th Mar 20212:40 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAcquisition
25th Feb 20217:00 amRNSFinal Results
16th Feb 20217:00 amRNSNotice of Results
5th Feb 20217:00 amRNSAppointment of Sole Broker
14th Dec 20207:00 amRNSCompany Secretary Change
19th Nov 20207:01 amRNSBoard Changes
19th Nov 20207:00 amRNSTrading Update
5th Oct 20202:38 pmRNSDirector/PDMR Shareholding
15th Sep 202012:06 pmRNSHalf-year Report
2nd Sep 20201:00 pmRNSDirector/PDMR Shareholding
27th Aug 20207:00 amRNSHalf-year Report
6th Jul 20207:00 amRNSTrading Update
25th Jun 202012:08 pmRNSSecond Price Monitoring Extn
25th Jun 202012:03 pmRNSPrice Monitoring Extension
16th Jun 20203:59 pmRNSHolding(s) in Company
18th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20209:30 amRNSChange of Company Secretary
13th May 20209:30 amRNSResult of AGM
12th May 202012:00 pmRNSAGM Statement
5th May 202010:00 amRNSDisclosure of rights attached to equity shares
9th Apr 20204:30 pmRNSNotice of AGM
6th Apr 20207:00 amRNSAnnual Report 2019
30th Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
2nd Mar 202012:08 pmRNSSecond Price Monitoring Extn
2nd Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSAnnual Results 2019
28th Jan 202010:00 amRNSNotice of Results
20th Nov 20197:00 amRNSTrading Update
11th Oct 20191:27 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSTotal Voting Rights
10th Sep 201911:28 amRNSHalf-year Report
2nd Sep 201912:00 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSAcquisition
22nd Aug 20197:00 amRNSHalf-year Report
7th Aug 20198:02 amRNSNotice of Interim results
31st Jul 20197:46 amRNSHolding(s) in Company
31st May 20198:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.